Pharmacy

ARRENO Aggrenox

Home » Prescription Drugs 2 » ARRENO Aggrenox

The combination of aspirin and extended-release dipyridamole is in a class of drugs called antiplatelet agents. It works by preventing excessive blood clotting. It is used to reduce the risk of stroke in patients who have had or are at risk of stroke.The combination of aspirin and extended-release dipyridamole comes as a capsule to take by mouth. It is usually taken twice a day one capsule in the morning and one in the evening. Aspirin and extended-release dipyridamole should be swallowed whole. Do not open crush break or chew the capsules.The combination of aspirin and extended-release dipyridamole decreases the risk of having a stroke but does not eliminate that risk. Continue to take aspirin and extended-release dipyridamole even if you feel well. Do not stop taking aspirin and extended-release dipyridamole without talking to your doctor.

Buy ARRENO Aggrenox and other Prescription Drugs 2 products online at Medstore.

Buy Online at Medstore - Click Here!

About ARRENO Aggrenox:

Product Type: Prescription Drugs 2

ARRENO ( Aggrenox Generic Aspirin/Dipyridamole )

ARRENO (Aggrenox Generic Aspirin/Dipyridamole)

Aggrenox Generic Aspirin/Dipyridamole

25/200mg 3 x 60 Capsules-ER 60 Capsule-ER 2 x 60 Capsules-ER Aggrenox Generic Aspirin/Dipyridamole ARRENO

View more Prescription Drugs 2

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.